SEBI v. Birla Pacific Medspa Ltd and others (IPO proceeds diversion and listing-day price support, 2022)

Judgment entered

✓ Checked against the primary document on October 8, 2026. The library's summary, tags and figures for this record were compared with the regulator's own document by an AI model (Claude) following written instructions, in a single reading of the order; an independent second reading of 60 SEBI records agreed on every field for 56, the four misses being penalty amounts. No lawyer has reviewed them. A checked record can still contain errors, and checked does not mean endorsed. See how we check records or report a correction.

Report an error in this record (sebi-63453-misleading-issuer-disclosure-2022) by email

In September 2022 a SEBI adjudicating officer penalised Birla Pacific Medspa, its directors and others a combined Rs 3.42 crore over a 2011 IPO whose proceeds the order finds were diverted, in part to prop up the share price on listing day. The order also finds the company's later disclosures about use of the funds were misleading.

The record

What was ordered

Civil penalty

—

Disgorgement

—

Prejudgment interest

—

Total relief

—

Alleged gain

—

Penalty as published

34.2m INR

A dash means the release did not state a figure we could extract, not that the figure is zero. Penalty and disgorgement are stored separately so aggregates across the library do not double-count the same dollars. This regulator states penalties in INR. The figure is recorded as published and is not converted, so it does not appear in the USD totals or medians used elsewhere on this site.

What is alleged to have happened

The matter concerns the 2011 initial public offering of Birla Pacific Medspa Ltd, a company listed on BSE, which SEBI investigated because the share price swung sharply on its listing day, closing far above the issue price. The adjudicating officer's order was issued on 28 September 2022 and names the company, several current and former directors and other individuals as noticees. One former director, Vijay Agarwal, was not penalised, because the officer found his position different from that of the other directors.

SEBI alleged that the company stated in its offer documents that the money would fund new spa outlets, brand promotion and working capital, but instead diverted a large part of the proceeds. According to the order, about Rs 34.91 crore of the Rs 65.17 crore raised was siphoned off, and some of the money was channelled to third parties who used it to buy the company's own shares and support the price on listing day. The order also finds that quarterly filings given to the exchange did not reflect the true use of the funds.

The officer found that the company and one director breached the fraud-prevention rules in the PFUTP Regulations and section 12A of the SEBI Act through the price-support scheme, and that the company and nine individuals breached the same provisions through the misutilisation of IPO funds and the misleading reporting. The company was also found to have ignored SEBI summons and to have breached listing-agreement disclosure clauses.

The penalties, in rupees, were Rs 1.09 crore on the company across four provisions, Rs 25 lakh each on most directors, and Rs 32 lakh and Rs 26 lakh on two directors who also faced listing-agreement findings. These sum to Rs 3.42 crore; Rs 2 lakh of the company's amount, imposed under section 23E of the securities contracts law, is payable only depending on the outcome of a pending Supreme Court appeal in a different case.

The record does not show whether any noticee appealed, whether the penalties were collected, or the amount of any investor losses. Funds placed in inter-corporate deposits were expressly left outside this proceeding.

This library tags the matter as misleading issuer disclosure and price manipulation. The tagging is ours, not the regulator's.

For the regulator's own account of the facts, read the primary document linked above. This page deliberately summarises the structured record rather than reproducing the order.

What technique is this, and how does it work?

This action is tagged with 2 techniques in our taxonomy. The tagging is ours: regulators charge statutory provisions, not technique names, so the mapping is an editorial judgement described in our editorial policy.

• Misleading issuer disclosure — see how it works, what statute it engages, and every other action tagged the same way.
• Price manipulation — see how it works, what statute it engages, and every other action tagged the same way.

Timeline

1. 2022-09-28 SEBI order

Primary documents

Everything on this page derives from the documents below. Where our summary and the primary document disagree, the primary document is right.

• SEBI order

The linked release is published by the issuing regulator under its own terms. Our summary and narrative above are our own writing.

Related actions

Other actions in the library sharing at least one technique tag with this one.

Record added October 8, 2026. submit a correction.